A PET scan is an effective way to examine the chemical activity in parts of your body. It may help identify a variety of conditions, including some cancers, heart disease and brain disorders. The pictures from a PET scan provide information different from that uncovered by other types of scans, such as computerized tomography (CT) or magnetic resonance imaging (MRI). A PET scan or a combined CT-PET scan enables your doctor to better diagnose your condition.
Cancer cells show up as bright spots on PET scans because they have a higher metabolic rate than do normal cells. PET scans may be useful in:
- Detecting cancer
- Revealing whether your cancer has spread
- Checking whether a cancer treatment is working
- Finding a cancer recurrence
PET scans must be interpreted carefully because noncancerous conditions can look like cancer, and many types of cancer do not appear on PET scans. The types of cancer most likely to show up on PET scans include:
- Head and neck
PET scans can reveal areas of decreased blood flow in the heart. This information can help you and your doctor decide, for example, whether you might benefit from a procedure to open clogged heart arteries (angioplasty) or coronary artery bypass surgery.
PET scans can be used to evaluate certain brain disorders, such as:
May 06, 2014
- Alzheimer's disease
- Javery O, et al. FDG PET or PET/CT in patients with pancreatic cancer: When does it add to diagnostic CT or MRI? Clinical Imaging 37;2013:295.
- Murphy JG, et al., eds. Mayo Clinic Cardiology: Concise Textbook. 4th ed. New York, N.Y.: Oxford University Press; 2013:130.
- Ziessman HA, et al. Nuclear Medicine: The Requisites. 4th ed. Philadelphia, Pa.: Saunders Elsevier; 2014.
- Positron emission tomography — Computed tomography (PET/CT). Radiological Society of North America. http://www.radiologyinfo.org/en/info.cfm?pg=PET. Accessed Dec. 11, 2013.
- About nuclear medicine and molecular imaging. Society of Nuclear Medicine and Molecular Imaging. http://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=6433&navItemNumber=756. Accessed Dec. 11, 2013.
- About PET scans. American College of Radiology Imaging Network. http://www.acrin.org/patients/aboutimagingexamsandagents/aboutpetscans.aspx. Accessed Dec. 11, 2013.
- Riggin EA. Decision Support System. Mayo Clinic, Rochester, Minn. Nov. 20, 2013.
- AskMayoExpert. Lung cancer surveillance in at-risk patients. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
- Mitchell CR, et al. Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment. Journal of Urology. 2013;189:1308.
- ACR appropriateness criteria pretreatment staging of colorectal cancer. Rockville, Md.: Agency for Healthcare Research and Quality. http://www.guideline.gov/content.aspx?id=35139. Accessed Dec. 19, 2013.
- FDA approves production of imaging agent that helps detect prostate cancer. U.S. Food and Drug Administration. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm319201.htm. Accessed Dec. 18, 2013.